title: Author's reply to comments to: Ranibizumab for persistent diabetic macular edema after bevacizumab treatment.
authors.affiliation: The Goldschleger Eye Institute, Sheba Medical Center, Tel Aviv - Israel.
authors.forename: Gabriel
authors.initials: G
authors.lastname: Katz
mesh_terms: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D003930:Diabetic Retinopathy; D006801:Humans; D058449:Intravitreal Injections; D008269:Macular Edema; D000069579:Ranibizumab; D042461:Vascular Endothelial Growth Factor A; D014792:Visual Acuity
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab; D000069579:Ranibizumab